This inventor holds 0 USPTO granted patents, plus 3 CIPO patents and 1 EPO patent.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: The Innovations of Harry Brittain
Introduction
Harry Brittain is an accomplished inventor based in Milford, NJ (US). He has made significant contributions to the field of therapeutic compounds, particularly in the area of transmucosal absorption. His work focuses on improving the administration of medications to enhance their effectiveness and patient outcomes.
Latest Patents
Harry Brittain holds a patent for "Compositions And Methods For Transmucosal Absorption." This invention provides compositions and methods for administering therapeutic compounds, specifically cyclobenzaprine or amitriptyline, for transmucosal absorption. The compositions include a basifying agent alongside the therapeutic agent, offering surprising pharmacokinetic benefits over traditional oral administration. Additionally, methods for treating fibromyalgia in human subjects are also included in this patent.
Career Highlights
Harry Brittain is currently associated with Tonix Pharma Holdings Limited, where he continues to innovate in the pharmaceutical field. His work is pivotal in developing new methods for drug delivery that can significantly improve patient care.
Collaborations
Harry has collaborated with notable colleagues such as Seth Lederman and Giorgio Reiner, contributing to advancements in therapeutic methodologies.
Conclusion
Harry Brittain's innovative work in transmucosal absorption represents a significant advancement in the field of pharmaceuticals. His contributions are poised to enhance the treatment of conditions like fibromyalgia, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile